Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn’s Disease (Q22252310)

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Review article: Crohn's disease: monitoring disease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

C-reactive protein: anti-placebo or predictor of response

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

C-reactive protein reassessed

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

C-reactive protein as a marker for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Indications for investigation of chronic gastrointestinal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

An index of inflammatory activity in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

Predicting outcome in severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CGH.2006.02.003

7 January 2021

10.1016/J.CGH.2006.02.003

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3991620

3991620

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference